Skip to content

A Comparative Study of the Air-Q ILA and the ILMA for Ventilation and Intubation

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01209559
Enrollment
0
Registered
2010-09-27
Start date
2011-01-31
Completion date
2011-01-31
Last updated
2018-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management

Brief summary

The objective of this study is to determine if the glottic view obtained with the air-Q Intubating Laryngeal Airway (air-Q ILA, Cookgas LLC®, Mercury Medical®, Clearwater, FL, USA) is better than that obtained with the traditionally used intubating laryngeal mask airway (LMA FastrachTM or ILMA, LMA North America Inc., San Diego, CA). The study will also compare effectiveness of ventilation.

Interventions

None listed

Sponsors

Nova Scotia Health Authority
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* healthy ASA class I and II patients scheduled for elective surgery under general anesthesia requiring the use of the LMA

Exclusion criteria

* history of acid reflux, * a BMI ≥ 40kg.m-2, * require endotracheal intubation, * have predictors of difficult intubation, * not candidates for insertion of an ILMA or LMA, including a mouth opening of less than 2.5 cm, * cannot consent to the study

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026